SPBC215.06c Antibody

What is the function of SPBC215.06c protein in Schizosaccharomyces pombe?

SPBC215.06c is a protein in fission yeast that functions similarly to mammalian phosphoinositide-dependent protein kinases, which act as signaling hubs in cellular processes. Like other PDK homologs such as Ksg1 and Ppk21, SPBC215.06c likely plays important roles in cell cycle progression and cellular signaling pathways . These proteins participate in regulating critical cell functions through phosphorylation of downstream targets involved in growth, division, and stress responses.

What applications are suitable for SPBC215.06c antibodies in research?

SPBC215.06c antibodies are valuable tools for multiple research applications including:

• Western blotting to detect protein expression levels

• Immunofluorescence microscopy to determine subcellular localization

• Immunoprecipitation to identify protein interaction partners

• Flow cytometry to analyze protein expression in cell populations

• Chromatin immunoprecipitation (ChIP) if the protein has DNA-binding properties

When selecting appropriate applications, researchers should consider the validation data provided with commercially available antibodies, similar to those available for other S. pombe proteins .

How can I validate the specificity of my SPBC215.06c antibody?

Validating antibody specificity is critical for reliable research results. For SPBC215.06c antibody, implement the following validation strategy:

• Genetic controls: Test the antibody on wildtype cells versus SPBC215.06c deletion mutants

• Overexpression controls: Compare signal between normal expression and cells overexpressing tagged SPBC215.06c

• Peptide competition assay: Pre-incubate antibody with purified antigen peptide to block specific binding

• Cross-reactivity assessment: Test on closely related proteins (e.g., other PDK homologs)

• Multiple detection methods: Confirm findings using different techniques (Western blot, immunofluorescence)

This comprehensive validation approach ensures that observed signals truly represent SPBC215.06c protein rather than non-specific binding .

What are the recommended protocols for immunoprecipitation using SPBC215.06c antibody?

For successful immunoprecipitation of SPBC215.06c and its interaction partners:

• Cell lysis buffer optimization:

  • Standard buffer: 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, 1 mM EDTA

  • For phosphorylated proteins: Add phosphatase inhibitors (10 mM NaF, 1 mM Na₃VO₄)

  • Protease inhibitor cocktail is essential

• Immunoprecipitation procedure:

  • Pre-clear lysate with protein A/G beads (1 hour, 4°C)

  • Incubate cleared lysate with 2-5 μg antibody overnight at 4°C

  • Add protein A/G beads for 2-4 hours

  • Wash 4-5 times with lysis buffer containing reduced detergent (0.1% NP-40)

  • Elute with sample buffer or gentle elution for downstream mass spectrometry

• Controls:

  • Input sample (5-10% of lysate)

  • IgG control (same species as SPBC215.06c antibody)

  • No-antibody control

  • Deletion mutant control

This protocol can be adapted from methods used for immunoprecipitation of similar kinases like Ksg1 or Ppk21 .

What are the best fixation methods for immunofluorescence with SPBC215.06c antibody?

For optimal immunofluorescence results with SPBC215.06c antibody in S. pombe:

For SPBC215.06c visualization, the combined fixation approach often yields the best results, similar to what has been observed with other kinases in the PDK family. After fixation, use 1% BSA in PBS with 0.1% Triton X-100 for blocking and antibody incubation .

How can I use phospho-specific antibodies to study SPBC215.06c activity in different cell cycle phases?

Phosphorylation states of SPBC215.06c may vary throughout the cell cycle, similar to related kinases:

• Custom phospho-specific antibody development:

  • Identify potential phosphorylation sites through sequence analysis and comparison with known PDK homologs

  • Design peptides containing phosphorylated residues for immunization

  • Validate phospho-specificity through lambda phosphatase treatment controls

• Cell synchronization methods for cell cycle analysis:

  • Nitrogen starvation and release

  • Hydroxyurea block and release

  • Temperature-sensitive cdc25 mutant arrest and release

• Detection methods:

  • Western blotting with phospho-specific antibodies at different time points

  • Flow cytometry combining DNA content and phospho-SPBC215.06c detection

  • Immunofluorescence microscopy correlating phospho-signal with cell cycle markers

This approach has proven effective for studying the phosphorylation dynamics of related kinases involved in cell cycle regulation in S. pombe .

What strategies can I use to investigate the interaction between SPBC215.06c and other cell cycle regulators?

To comprehensively map SPBC215.06c interactions with cell cycle regulators:

• Proximity-based labeling:

  • Generate SPBC215.06c-BioID or TurboID fusion proteins

  • Express in S. pombe cells and induce biotinylation

  • Purify biotinylated proteins and identify by mass spectrometry

• Yeast two-hybrid screening:

  • Use SPBC215.06c as bait against an S. pombe cDNA library

  • Focus on interactions with known cell cycle regulators like Cdr2, Ppk21, or Cdc25

• Co-immunoprecipitation coupled with targeted MS:

  • Immunoprecipitate SPBC215.06c using validated antibodies

  • Perform targeted mass spectrometry for known cell cycle regulators

  • Quantify interactions under different conditions (cell cycle phases, stress)

• Genetic interaction mapping:

  • Generate double mutants of SPBC215.06c with cell cycle regulators

  • Assess synthetic phenotypes indicating functional relationships

  • Similar to approaches used to study Ksg1 and Ppk21 genetic interactions

How can I analyze SPBC215.06c kinase activity in vitro using purified recombinant protein?

For robust in vitro kinase assays with recombinant SPBC215.06c:

• Protein expression and purification:

  • Express full-length or catalytic domain in E. coli or insect cells

  • Include purification tags (His, GST) for efficient isolation

  • Verify purity by SDS-PAGE and activity by preliminary kinase assays

• Kinase assay setup:

  • Reaction buffer: 50 mM Tris-HCl pH 7.5, 10 mM MgCl₂, 1 mM DTT

  • ATP concentration: 100 μM (include 0.1-1 μCi [γ-³²P]ATP for radioactive assays)

  • Substrate options: Generic substrates (MBP, histone H1) or candidate physiological substrates

  • Incubation: 30 minutes at 30°C

• Activity quantification methods:

  • Radioactive assay: Measure ³²P incorporation by scintillation counting or phosphorimaging

  • Non-radioactive assay: Use phospho-specific antibodies or ADP-Glo technology

  • Mass spectrometry: Identify specific phosphorylation sites on substrates

• Controls:

  • Kinase-dead mutant (typically K→R mutation in catalytic site)

  • No-ATP control

  • Phosphatase-treated substrate controls

This methodology parallels approaches used for characterizing other PDK family kinases in yeast systems .

Why might I observe weak or no signal when using SPBC215.06c antibody in Western blotting?

Several factors can contribute to weak or absent signals when detecting SPBC215.06c:

• Protein expression levels:

  • SPBC215.06c may be expressed at low levels under standard conditions

  • Consider using overexpression systems or concentrating samples

  • Check expression under different growth conditions or cell cycle phases

• Protein extraction efficiency:

  • S. pombe cell walls are resistant to standard lysis methods

  • Use optimized extraction protocols with mechanical disruption (glass beads)

• Antibody-specific factors:

  • Primary antibody concentration may need adjustment

  • Extended incubation times (overnight at 4°C)

  • Different blocking agents (BSA vs. milk protein)

  • Alternative membrane types (PVDF vs. nitrocellulose)

• Detection system sensitivity:

  • Enhanced chemiluminescence (ECL) reagents vary in sensitivity

  • Consider fluorescent secondary antibodies with direct scanning

  • Loading controls should confirm adequate protein presence

How can I improve the signal-to-noise ratio in immunofluorescence with SPBC215.06c antibody?

To enhance specific signal while reducing background in immunofluorescence:

• Fixation optimization:

  • Test different fixation protocols (see section 2.3)

  • Freshly prepared fixatives improve results

  • Control fixation time carefully

• Blocking improvements:

  • Extended blocking (2+ hours at room temperature)

  • Alternative blocking agents (normal serum matching secondary antibody species)

  • Addition of 0.1% Tween-20 or 0.1% Triton X-100 to blocking buffer

• Antibody incubation modifications:

  • Dilute antibodies in fresh blocking buffer

  • Incubate primary antibody overnight at 4°C

  • Increase wash steps (5-6 washes, 10 minutes each)

• Mounting and imaging considerations:

  • Anti-fade mounting media reduce photobleaching

  • Confocal microscopy improves signal-to-noise ratio

  • Image deconvolution software can enhance specific signals

These approaches have successfully improved detection of low-abundance proteins in S. pombe .

What are the potential cross-reactivity concerns with SPBC215.06c antibody and how can they be addressed?

Cross-reactivity risks and mitigation strategies:

• Potential cross-reactive proteins:

  • Other PDK homologs (Ppk21, Ksg1) share sequence homology with SPBC215.06c

  • Kinase domains often contain conserved regions that may cross-react

  • Regulatory proteins in the same pathways may be recognized

• Validation approaches:

  • Test antibody on deletion strains of SPBC215.06c and related proteins

  • Epitope mapping to identify unique regions for antibody recognition

  • Peptide competition assays with specific and related peptides

• Analytical strategies:

  • When possible, use tagged versions of SPBC215.06c with tag-specific antibodies

  • Combine antibody detection with mass spectrometry verification

  • Use genetic approaches (mutants, depletions) to confirm antibody specificity

• Advanced solutions for persistent cross-reactivity:

  • Custom antibody production against unique regions of SPBC215.06c

  • Immunodepletion of cross-reactive antibodies from polyclonal preparations

  • CRISPR-mediated epitope tagging of endogenous SPBC215.06c

Cross-reactivity assessment is particularly important when studying proteins with significant homology to other cellular components .

How can I utilize SPBC215.06c antibodies to investigate its role in cell cycle checkpoint regulation?

To examine SPBC215.06c's potential role in checkpoint regulation:

• Checkpoint activation experiments:

  • Expose cells to checkpoint-activating stresses (DNA damage, replication inhibitors)

  • Monitor SPBC215.06c protein levels, phosphorylation, and localization using validated antibodies

  • Compare responses in wildtype versus checkpoint-defective mutants (rad3Δ, chk1Δ)

• Chromatin association studies:

  • Perform chromatin fractionation to separate soluble and chromatin-bound proteins

  • Detect SPBC215.06c distribution using specific antibodies

  • Analyze changes in chromatin association throughout cell cycle or after checkpoint activation

• Sophisticated co-localization analyses:

  • Combine SPBC215.06c antibody staining with markers for:

    • DNA damage sites (γH2A.X)

    • Replication forks (PCNA)

    • Spindle checkpoint components (Mad2, Bub1)

  • Utilize super-resolution microscopy for precise localization

• Quantitative phosphoproteomics:

  • Compare phosphoproteomes of wildtype vs. SPBC215.06c mutants during checkpoint activation

  • Identify altered phosphorylation events in checkpoint signaling pathways

  • Validate findings using phospho-specific antibodies

This multi-faceted approach parallels methods used to study kinases like Ksg1 in cell cycle regulation .

What methods can I use to map the complete set of SPBC215.06c binding partners and substrates?

For comprehensive mapping of SPBC215.06c interactome and substrates:

• Interactome mapping techniques:

  • Proximity labeling (BioID, TurboID) fused to SPBC215.06c

  • Quantitative affinity purification coupled with mass spectrometry (AP-MS)

  • Yeast two-hybrid screening with domain-specific baits

  • Protein complementation assays (split-Venus, split-luciferase)

• Substrate identification approaches:

  • Analog-sensitive SPBC215.06c mutants (gatekeeper mutations) with bulky ATP analogs

  • Phosphoproteomics comparing wildtype vs. SPBC215.06c mutants

  • In vitro kinase assays with protein/peptide libraries

  • Bioinformatic prediction of substrates based on consensus motifs

• Validation of direct interactions and substrates:

  • In vitro binding assays with recombinant proteins

  • Mutational analysis of binding interfaces or phosphorylation sites

  • In vivo phosphorylation site mapping by mass spectrometry

  • Functional assays to confirm biological relevance of interactions

This systematic approach has been successfully applied to characterize kinase interactions in fission yeast, revealing functional redundancy and pathway interconnections .

How can I develop a reliable CRISPR-based tagging strategy for endogenous SPBC215.06c to complement antibody-based detection?

Developing an endogenous tagging system for SPBC215.06c:

• CRISPR-Cas9 design for S. pombe:

  • Select specific gRNAs targeting the C-terminus of SPBC215.06c

  • Design repair templates with tag sequences (mEGFP, 3xFLAG, V5, etc.)

  • Include flexible linkers (GGGGS)₂ to minimize functional disruption

  • Add selection markers (kanMX6, natMX6) for transformant selection

• Validation of tagged strain functionality:

  • Growth rate comparison with wildtype strains

  • Microscopic analysis of cell morphology

  • Functional assays relevant to SPBC215.06c (cell cycle progression)

  • Compare protein localization with antibody-based detection

• Optimized detection protocols for tagged protein:

  • Live-cell imaging for fluorescent tags

  • Chromatin immunoprecipitation for DNA-associated functions

• Advanced applications of tagged strains:

  • FRAP (Fluorescence Recovery After Photobleaching) for protein dynamics

  • BiFC (Bimolecular Fluorescence Complementation) for in vivo interaction studies

  • Auxin-inducible degron for rapid protein depletion studies

These tagging approaches can complement antibody-based detection and provide additional tools for studying SPBC215.06c function .

What emerging technologies might enhance SPBC215.06c antibody applications in the future?

Several cutting-edge technologies are poised to revolutionize antibody applications for proteins like SPBC215.06c:

• Next-generation antibody engineering:

  • Single-domain nanobodies with enhanced penetration into cellular structures

  • Bispecific antibodies targeting SPBC215.06c and interacting partners simultaneously

  • Intrabodies expressed within cells for live detection of native protein

• Advanced imaging technologies:

  • Expansion microscopy for super-resolution imaging of SPBC215.06c localization

  • Lattice light-sheet microscopy for long-term live imaging with minimal phototoxicity

  • Correlative light and electron microscopy (CLEM) for ultrastructural context

• Single-cell technologies:

  • Spatial proteomics combining antibody detection with subcellular resolution

  • Single-cell Western blotting for heterogeneity analysis in cell populations

  • Mass cytometry (CyTOF) with metal-conjugated antibodies for multi-parameter analysis

• Artificial intelligence applications:

  • Deep learning algorithms for improved image analysis and protein localization

  • Predictive modeling of antibody-epitope interactions for enhanced design

  • Automated experimental design for antibody validation and optimization

These technologies will expand the capabilities of SPBC215.06c antibodies beyond current applications, enabling more sophisticated studies of this important protein's functions.

How should researchers integrate antibody-based approaches with genetic and biochemical methods for comprehensive SPBC215.06c characterization?

A multi-modal strategy for SPBC215.06c characterization:

• Integrated experimental workflows:

  • Begin with genetic approaches (deletions, mutations) to establish phenotypes

  • Apply biochemical methods to identify interaction partners and modifications

  • Use antibody-based approaches to validate and extend these findings in vivo

  • Combine approaches to address discrepancies between different methods

• Cross-validation framework:

  • Confirm antibody-detected localization with fluorescently-tagged proteins

  • Validate antibody-detected interactions with genetic epistasis analysis

  • Support antibody-identified modifications with mass spectrometry

  • Address contradictions through careful controls and alternative approaches

• Data integration strategies:

  • Correlate protein abundance (antibody detection) with transcript levels (RNA-seq)

  • Map protein interactions (immunoprecipitation) to genetic interactions (synthetic lethality)

  • Connect protein modifications (phospho-antibodies) with functional outcomes

  • Build systems-level models integrating all data types

This holistic approach has proven valuable for characterizing complex cellular pathways involving kinases like those in the PDK family .